Yvonne Romero
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Yvonne Romero has a total of 162 co-authors. Here are the top co-authors by number of shared publications:
- Joseph Anthony Murray
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
11 shared publications - David A. Katzka
Division of Digestive and Liver Diseases Columbia University Irving Medical Center New York New York USA
8 shared publications Debra M. Geno
Mayo Clinic
7 shared publications- Felicity Enders
Mayo Clinic
7 shared publications - Ganapathy A. Prasad
Barrett's Esophagus Unit, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA
6 shared publications - Jeffrey A. Alexander
Mayo Clinic
6 shared publications
Latest Publications
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S190
957 Development and Validation of an Endoscopy-Based Activity Index for Adults With Eosinophilic Esophagitis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S190
957 Development and Validation of an Endoscopy-Based Activity Index for Adults With Eosinophilic Esophagitis
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S663-S664
Mo1186 Caregiver-Assessed EoE Activity in Children Between 3-9 Years of Age Poorly Correlates With Physician Global Assessment, Endoscopic or Histologic Activity
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S663-S664
Mo1186 Caregiver-Assessed EoE Activity in Children Between 3-9 Years of Age Poorly Correlates With Physician Global Assessment, Endoscopic or Histologic Activity
- 22 January 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (1) , 146-162
Once-Daily Omeprazole/Sodium Bicarbonate Heals Severe Refractory Reflux Esophagitis with Morning or Nighttime Dosing
Morning dose or twice-daily proton pump inhibitor (PPI) use is often prescribed to heal severe reflux esophagitis.
- 22 January 2014
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 60 (1) , 146-162
Once-Daily Omeprazole/Sodium Bicarbonate Heals Severe Refractory Reflux Esophagitis with Morning or Nighttime Dosing
Morning dose or twice-daily proton pump inhibitor (PPI) use is often prescribed to heal severe reflux esophagitis.
- 20 January 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (3) , 97
Relationship of initial quality-of-life deficit and survival in esophageal cancer (EC): The Mayo Clinic Romero Registry experience.
97 Background: A diagnosis of EC significantly impairs patient (pt)’s survival and quality of life (QoL). We explored the relationship between pt-assessed QoL and survival. Methods: The Mayo Clinic Romero (formerly Esophageal Adenocarcinoma-Barrett's Esophagus) Registry prospectively collects clinical data during a pt's treatment course. QoL is recorded at enrollment (baseline) and annually using a validated 12-item Linear Analog Self-Assessment (LASA). A 10-pt scale is applied; ≤5 was termed clinically deficient QoL. Initial TNM staging, clinical (age, sex, prior chemotherapy, and esophagectomy), and socioeconomic variables (marital/employment status) were analyzed using Cox proportional hazards regression models. Results: 836 pts were analyzed. Median age was 64 years. 166, 506 and 164 pts had early, locally advanced, and metastatic EC, with 5-year survival rates of 75.1%, 33.6%, and 8.1%, respectively (P≤.0001). Poorer survival rates were seen in clinically QoL deficient pts in the following categories: Overall QoL (Hazard Ratio [H.R.] 0.66; 95% C.I., 0.54-0.80; P≤.0001) and LASA subsets for physical (H.R. 0.68; 95% C.I., 0.57-0.82; P≤.0001), emotional well-being (H.R. 0.69; C.I., 0.57-0.84; P=.0003), and social activity (H.R. 0.76; C.I., 0.63-0.91; P=.0028). No difference in survival was observed for marital or employment status, familial support, and financial/legal concerns. Pts with esophagectomy prior to LASA evaluation had improved survival (H.R. 0.68; 95% C.I., 0.55-0.85; P=.0005). No survival difference was observed whether pts received chemotherapy, before or after their baseline LASA evaluation. Conclusions: A strong association exists between pt’s overall survival and better overall QOL, physical, emotional well-being, and social activities. Using LASA to clinically monitor QoL at specified intervals may afford providers the opportunity to intervene when patients begin to experience QoL decline. The determinants of clinically deficit QoL and its impact on survival warrant further translational and prospective research.
- 20 January 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (3) , 97
Relationship of initial quality-of-life deficit and survival in esophageal cancer (EC): The Mayo Clinic Romero Registry experience.
97 Background: A diagnosis of EC significantly impairs patient (pt)’s survival and quality of life (QoL). We explored the relationship between pt-assessed QoL and survival. Methods: The Mayo Clinic Romero (formerly Esophageal Adenocarcinoma-Barrett's Esophagus) Registry prospectively collects clinical data during a pt's treatment course. QoL is recorded at enrollment (baseline) and annually using a validated 12-item Linear Analog Self-Assessment (LASA). A 10-pt scale is applied; ≤5 was termed clinically deficient QoL. Initial TNM staging, clinical (age, sex, prior chemotherapy, and esophagectomy), and socioeconomic variables (marital/employment status) were analyzed using Cox proportional hazards regression models. Results: 836 pts were analyzed. Median age was 64 years. 166, 506 and 164 pts had early, locally advanced, and metastatic EC, with 5-year survival rates of 75.1%, 33.6%, and 8.1%, respectively (P≤.0001). Poorer survival rates were seen in clinically QoL deficient pts in the following categories: Overall QoL (Hazard Ratio [H.R.] 0.66; 95% C.I., 0.54-0.80; P≤.0001) and LASA subsets for physical (H.R. 0.68; 95% C.I., 0.57-0.82; P≤.0001), emotional well-being (H.R. 0.69; C.I., 0.57-0.84; P=.0003), and social activity (H.R. 0.76; C.I., 0.63-0.91; P=.0028). No difference in survival was observed for marital or employment status, familial support, and financial/legal concerns. Pts with esophagectomy prior to LASA evaluation had improved survival (H.R. 0.68; 95% C.I., 0.55-0.85; P=.0005). No survival difference was observed whether pts received chemotherapy, before or after their baseline LASA evaluation. Conclusions: A strong association exists between pt’s overall survival and better overall QOL, physical, emotional well-being, and social activities. Using LASA to clinically monitor QoL at specified intervals may afford providers the opportunity to intervene when patients begin to experience QoL decline. The determinants of clinically deficit QoL and its impact on survival warrant further translational and prospective research.
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1315 Three-Dimensional Volume of Inverted Impedance (VII): A Novel Method to Measure Bolus Transit Using High-Resolution Impedance Manometry and Its Relationship to Key Parameters of the Chicago Classification Based on an Asymptomatic Normal Population
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1315 Three-Dimensional Volume of Inverted Impedance (VII): A Novel Method to Measure Bolus Transit Using High-Resolution Impedance Manometry and Its Relationship to Key Parameters of the Chicago Classification Based on an Asymptomatic Normal Population
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1979 Fluorescence in Situ Hybridization Analysis on a Low-Risk Barrett's Esophagus Population
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Sa1979 Fluorescence in Situ Hybridization Analysis on a Low-Risk Barrett's Esophagus Population
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1877 Chicago Classification Normal Reference Range Significantly Altered When Patients Over Age 50 Included
- 1 May 2013
- Published by Elsevier in Gastroenterology
- Vol. 144 (5)
Su1877 Chicago Classification Normal Reference Range Significantly Altered When Patients Over Age 50 Included
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1106 Endoscopic Precursors of Barrett's Esophagus - Findings From a Population Based Cohort
- 1 May 2012
- Published by Elsevier in Gastroenterology
- Vol. 142 (5)
Tu1106 Endoscopic Precursors of Barrett's Esophagus - Findings From a Population Based Cohort
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Epidemiology and Clinical Characteristics of Eosinophilic Esophagitis in Korea: Based on Single Center Endoscopic Database
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Epidemiology and Clinical Characteristics of Eosinophilic Esophagitis in Korea: Based on Single Center Endoscopic Database
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Manometric Characteristics of Opioid Esophageal Dysmotility Disorder by High-Resolution Manometry
- 1 May 2011
- Published by Elsevier in Gastroenterology
- Vol. 140 (5)
Manometric Characteristics of Opioid Esophageal Dysmotility Disorder by High-Resolution Manometry